A Summary of Research at Bloedel
New Hope for Hearing Loss
Better Hearing Through Research
Research at the Bloedel Center
Resilience
Repair
Regeneration
Other Research
At the VMBHRC, collaborative research is the rule,
leading to a natural and fruitful sharing of ideas. A
broad-based multidisciplinary team of researchers
has been in place for many years, bringing a wide
range of strategies and expertise to bear in unraveling
the complex questions of how best to prevent,
repair, and reverse inner-ear disease including hearing
loss, tinnitus, and vestibular disorders.
New Hope for Hearing Loss
Hearing loss is the common chronic human disability: one in 10 Americans has enough hearing
loss to cause serious communication problems. In people over the age of 60, this number increases to 30
percent and then to more than 50 percent for those over 80 years of age. During the past two decades, progress
toward understanding the biological foundations of both normal and impaired hearing has been rapid. UW
scientists have played major roles in these advances, including pioneering the field of inner-ear hair cell
regeneration and significantly advancing knowledge in the areas of cochlear implants, hearing development,
genetics of hearing loss, vestibular testing, and early diagnosis of hearing loss in children.
Better Hearing Through Research
|
The University of Washington's Virginia Merrill Bloedel Hearing Research Center (VMBHRC)
houses an interdisciplinary group of researchers who study hearing, hearing loss, and related
communication disorders. The center's motto is 'Better Hearing
Through Research', its goal to advance knowledge in the auditory field so
that all may hear. The Bloedel Center was established in 1988 with a generous
gift from Prentice Bloedel and his wife, Virginia Merrill Bloedel,
who suffered from a progressive, and ultimately profound, hearing loss.
Today, through the center, 15 University departments and more than 60
affiliated research scientists from a variety of disciplines in three UW
schools and colleges (the School of Medicine, the College of Engineering,
and the College of Arts and Sciences) are working together. We seek to
conquer deafness and disequilibrium by preventing hearing loss and
through repair and regeneration once damage has occurred. The Bloedel
Center now comprises the largest hearing research group in the country.
Research at the Bloedel Center
Scientists whose research is conducted at the laboratories of the VMBHRC are investigating
several innovative approaches to understanding hearing resilience, repair, and regeneration.
Efforts are under way to understand cellular and molecular mechanisms, including genetic
triggers. Our researchers are working to improve technologies that are currently available, such
as the cochlear implant. Other technologies, such as hair-cell regeneration, are an exciting
approach that holds promise for tomorrow.
Resilience
Approximately one in 1,000 babies is born with significant hearing loss; about half of these
cases are due to an inherited genetic condition. Over the past decade, research in the laboratory
of Dr. Bruce Tempel has contributed to identifying these ?deafness genes? in mice and by
extension in humans. Of particular interest are genes that regulate calcium concentrations in
hair cells (sensory cells of the inner ear necessary for normal hearing), thereby affecting the
transduction of sound. Of equal interest are genes that maintain high-resolution action potential
encoding of auditory information in neurons of the auditory brainstem. Dr. Helen Brew
uses mice lacking specific ion channel genes to determine the role of these genes in normal
auditory transmission and their potential contribution to disease states including
tinnitus. Dr. Valerie Street uses molecular genetic techniques to identify
genes that cause low-frequency and progressive hearing loss in families where
the loss is first observed in teenagers or young adults. Research continues to
identify the genetic basis of these familial forms of hearing loss and to search for
ways to minimize their effects through hearing aids, training, drug development,
cochlear implants, and eventually gene therapy aimed at gene supplementation
or hair cell regeneration.
Cross-section image of a
chick's auditory brain
stem.
Recent discoveries about avian
hearing
have exciting implications
for the future of
hearing-loss
treatment in humans.
|
In comparison to frank mutations that are familial, much less is known about
the complex genetic contributions to hearing loss associated with aging or exposure
to noise. Age-related or noise-induced hearing loss comes on slowly in most
people but has a major impact, causing hearing loss and difficulties in communication
in roughly 50 percent of the population at retirement age.What can be
done to help prevent or resist these forms of cumulative hearing loss? Several research projects
at the VMBHRC are aimed at identifying gene targets and methods for preventing hearing loss.
In the laboratory of Dr. Tempel, strains of mice that show age-related hearing loss or are resistant
to noise exposure are being analyzed using a whole genome approach aimed at identifying
each of the multiple genes that contribute to making these mice uniquely susceptible to
aging or resilient to noise. Homologous genes in humans are likely to also contribute to similar
types of hearing loss in humans.
In Dr. Edwin Rubel's lab, zebrafish are being used to identify genes and chemical compounds
that influence the sensitivity of the inner ear to aging and potentially toxic agents such as therapeutic
drugs, noise exposure and environmental toxins. High throughput genetic screening
and high throughput testing with large chemical libraries are allowing VMBHRC scientists to
detect molecules and cellular pathways that alter the sensitivity of the inner ear to damage and
degeneration.
Efforts by these and other investigators will eventually identify basic mechanisms and provide
therapies aimed at increasing resilience and resistance to hearing loss.
Repair
Cochlear implants have proven to be an important advance in the quest to restore hearing.
Using this device, most deaf people can gain understanding of speech, provided the speech is
heard against a quiet background. Cochlear implants are limited, however. Currently they do
not provide good speech perception in noise, nor do they typically produce enough pitch perception
for a full appreciation of music. VMBHRC scientist Dr. Jay Rubinstein and his team
are studying ways to improve cochlear implant technology to reduce these limitations. Their
research is focusing on a signal processing approach for cochlear implants, which induces a
nerve response that is closer to that in normal hearing.Using recently developed sound-processing algorithms, music perception, spatial hearing, and speech perception in noise can be
improved, providing a better quality of life for cochlear implant users. It is possible that certain
vestibular disorders and forms of tinnitus may be treatable using advances in these technologies.
Although cochlear implants have made a remarkable impact on the rehabilitation of hearing
loss, they do not reproduce the temporal and spectral sensitivity of normal hearing. Dr.
Rubinstein?s work demonstrates that increased temporal sensitivity with cochlear implants can be produced with improved sound processing. Improving spectral sensitivity (the ability to discriminate pitch) demands a more biological approach such as that provided by work
described in the next section. Dr. Clifford Hume,working with Dr. Rubel, is identifying molecular mechanisms causing auditory neurons to connect to appropriate hair cells during normal development. This knowledge can be exploited to cause auditory neurons to grow toward and attach to cochlear implant electrodes. The results should lead to marked improvement in spectral resolution.
Dr. Olivia Bermingham-McDonogh is using tissue-specific knockout technology to look at
the post-natal requirement of neurotrophins for spiral ganglion cell survival. Investigating
what growth factors are important in the survival of spiral ganglion cells in the adult will provide
us the ability to engineer cochlear implants that may be coated with the appropriate factors
to encourage and enhance the survival of these ganglion cells.While it has been demonstrated
that electrical stimulation provides some trophic support to the spiral ganglion, it is
known that normal hair cells provide such support through a variety of other mechanisms that
could be emulated with such knowledge.
Regeneration
Loss of hair cells (the orange
structures in this
photo) is the
cause of most hearing
loss.
Researchers at VMBHRC were the
first to
discover that these cells
can be regenerated in
birds.
|
Most cases of hearing loss and balance dysfunction result from loss of sensory cells
(hair cells) in the inner ear. Hair cells are very sensitive and fragile. Loud noise,
aging, toxic medications, trauma, and genetic conditions can all destroy hair cells.
Over the past decade, regrowth of certain human cells has become a clinical reality.
For example, new skin can be grown in the laboratory and used to resurface burns.
We now know that new hair cells are produced after injury in some animals and can
be formed in the mammal inner ear under certain laboratory conditions. The search
to identify the conditions and factors that regulate cell regrowth is at the heart of
one of our research initiatives at the center.While the primary focus of the initiative
is on hair-cell regeneration, all the cell types in the inner ear will be examined.
Researchers at the VMBHRC at the University ofWashington were the first to discover hair-cell
regeneration in birds, and they continue to be the leaders in the field of hair-cell regeneration
research. They have validated that regeneration of inner-ear structures in mammals (as well as
birds) is possible. Dr. Rubel and his colleagues are now poised to take the next step in bringing
this possibility closer to reality.
Currently,VMBHRC scientists are working on distinct but complementary aspects of the haircell regeneration puzzle.
- Dr. Elizabeth Oesterle is studying the role of leukocytes, growth factors, and transcription
factors in promoting progenitor-cell division and hair-cell differentiation in mammalian
and avian inner ears.
- Dr. Jennifer Stone is characterizing hair cell progenitors and stem cells from the mature
avian inner ear and the role of transcription factors in promoting cell-cycle exit and haircell
differentiation in birds.
- Dr. Olivia Bermingham-McDonogh is delineating the role of growth factors and their
receptors in the development and maintenance of the differentiated cells in the cochlea. In
addition to studies on the mammalian cochlea, Dr. Bermingham-McDonogh, in collaboration
with Drs. Rubel, Stone and Oesterle, is investigating the gene expression changes that
occur during regeneration of the avian cochlea using microarray analysis.
- Dr. Clifford Hume is using molecular biology to design and test molecules to promote the
transition of undifferentiated stem cells into functional inner ear hair cells.
Other Research
Schematic drawing of the ear in
relation to
surrounding structures.
The inner ear (in blue)
is located
deep within the bones of the skull.
|
As we get older, our hearing begins to lose some of its sharpness and clarity. This process of
age-related hearing loss is known as presbycusis. Dr. George Gates and his research team are
studying the relationship between certain types of hearing tests and dementia in people who
are 65 years of age or older. They are investigating the use of central behavioral auditory tests,
such as the synthetic sentence identification test, in which a patient must identify sentences in
the presence of a background story being presented simultaneously to one ear. Dr. Gates
believes this test may be a predictor of Alzheimer?s disease. Findings from this research may be
applied to the development of clinical hearing tests that can help screen for early
stages of Alzheimer?s disease during routine hearing evaluations.
Dr. Patrick Feeney's research interest is the diagnosis of hearing loss due to middle-
ear disorders. Currently, techniques for testing and diagnosing middle-ear
function employ narrowband low-frequency sounds. Dr. Feeney's research focuses
on using wideband energy reflectance to study middle-ear function and development.
This method allows an earlier
and more accurate diagnosis of hearing
complications in newborns, infants,
and adults.
Dr. James Phillips studies the ear's
contribution to balance and vision. Dr. Phillips is
researching the creation of new testing methods for
the diagnosis of vestibular disorders, the co-development
of the vestibular and visual systems in infants
and children, and the neurophysiology of central
brainstem mechanisms controlling eye and head
coordination.
|